Latest

Oct 05, 2020, 08:00 ET Teva Canada announces availability of Aermony RespiClick™, an innovative new device for the treatment of bronchial asthma

Aermony RespiClick™ (fluticasone propionate inhalation powder), available in three dose options Asthma is a chronic, lifelong condition without a cure that can cause life-threatening symptoms and...


Aug 19, 2020, 08:00 ET Teva Canada announces product availability of AJOVY™

AJOVY™ is the first and only anti-CGRP treatment with both quarterly and monthly dosing for the preventive treatment of migraine in adults AJOVY™ is supported by the AJOVY™ Teva Support Solutions®...


May 19, 2020, 08:00 ET Teva Canada Secures Salbutamol Inhalers from its Global Supply Chain to Mitigate Shortage in Canadian Market

Teva Canada to be first company to import emergency supply of salbutamol inhalers - providing access to critically needed medication for Canadian patients TORONTO, May 19, 2020 /CNW/ - Teva Canada...


Apr 29, 2020, 08:00 ET Teva Canada announces the launch of AJOVY™ for the preventive treatment of migraine in adults who have at least four migraine days per month

AJOVYTM is the first and only anti-CGRP treatment with both quarterly and monthly dosing for the preventive treatment of migraine in adults AJOVYTM has been studied in patients with chronic or...


Apr 07, 2020, 07:30 ET Teva Canada Committed to Canadian Caregivers

- Expands Free Resources and Programs as Caregiving Demand Grows - April 7, 2020 National Caregivers Day | Connecting Caregivers and Pharmacists TORONTO, April 7, 2020 /CNW/ - During unprecedented...


Oct 31, 2019, 08:54 ET Teva Canada Announces the Launch of a Bioequivalent Generic Version of [Pr]Gilenya®, [Pr]Teva-Fingolimod Capsules for the treatment of Relapsing-Remitting Multiple Sclerosis (MS)

- Currently Available in Canada - TORONTO, Oct. 31, 2019 /CNW/ - Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries Ltd., announced the launch of PrTeva-Fingolimod 0.5 mg capsules, a ...


Sep 11, 2019, 10:14 ET Teva Canada Announces the Approval of HERZUMA®, a biosimilar to HERCEPTIN® for the treatment of adult patients with Early Breast Cancer, Metastatic Breast Cancer and Metastatic Gastric Cancer

This is the second Notice of Compliance (NOC) issued for a biosimilar in 2019 that Teva Canada Innovation will add to its portfolio of brands, generics and biosimilars. MONTREAL, Sept. 11, 2019 /CNW...


Apr 10, 2019, 08:00 ET Teva Canada Announces the Approval of TRUXIMA™, the first biosimilar to RITUXAN® in Canada for the Treatment of Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia and Rheumatoid Arthritis

MONTREAL, April 10, 2019 /CNW Telbec/ - Teva Canada Innovation, G.P.-.S.E.N.C. announces that Health Canada has granted a notice of compliance (NOC)1 for TRUXIMA™ (rituximab), the first biosimilar to ...


Apr 02, 2019, 07:30 ET Recognizing the Caregiver-Pharmacist Connection on National Caregiver Day

Teva Canada and Huddol collaborate to offer innovative solutions for Caregivers through the Pharmacy team April 2, 2019 is National Caregiver Day in Canada, where: Unpaid caregivers provide up to 75...


Dec 17, 2018, 14:53 ET VOLUNTARY RECALL - One (1) Lot (150261) of EQUATE™ LENS CARE SYSTEM (DIN 02387638) and EQUATE™ MULTI-PURPOSE SOLUTION (DIN 02291126) Due to a Labelling Error; Distributed by Teva Canada Limited

- Canadian Market Only - TORONTO, Dec. 17, 2018 /CNW/ - Teva Canada Limited, with the knowledge of Health Canada, is initiating a nationwide voluntary Type II recall of one (1) lot (listed above) of...


Sep 10, 2018, 12:10 ET Teva Canada Announces the Launch of a Generic Version of (PR)Abilify®, (PR)Teva-Aripiprazole Tablets for the treatment of Schizophrenia

- Currently Available in Canada - TORONTO, Sept. 10, 2018 /CNW/ - Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries Ltd., announces that the complete line of PrTeva-Aripiprazole (2...


May 10, 2018, 09:19 ET Teva Canada Announces the Launch of Teva-Cyclosporine® Ophthalmic Emulsion, the First Generic Version of Restasis® in Canada for the Treatment of Dry Eye Disease

- Currently Available in Canada - TORONTO, May 10, 2018 /CNW/ - Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries Ltd., announced the launch of Teva-Cyclosporine® ophthalmic...


Mar 22, 2018, 08:00 ET Teva Canada Announces the Launch of <C>ACT Methylphenidate ER® Tablets, a Generic Version of <C>Concerta® for the Treatment of ADHD

- Currently available in Canada - TORONTO, March 22, 2018 /CNW/ - Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries Ltd., announced that Health Canada has approved its application...


Mar 15, 2016, 09:00 ET Teva Canada Announces the Launch of (Pr)Teva-Abacavir/Lamivudine Tablets, a Generic of (Pr)Kivexa®

TORONTO, March 15, 2016 /CNW/ - Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries Ltd., announced that Health Canada has approved its application for the generic version of...


Feb 25, 2016, 09:00 ET Teva Canada Announces the Launch of (Pr)Teva-Tobramycin Inhalation Solution, a Generic of (Pr)Tobi®

TORONTO, Feb. 25, 2016 /CNW/ - Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries Ltd., announced that Health Canada has approved its application for the generic version of PrTobi®....


Jan 06, 2016, 11:41 ET Teva Canada Announces the Launch of (Pr)Teva-Tolterodine Tablets and (Pr)Teva-Tolterodine LA Extended Release Capsules, Generics of (Pr)Detrol® and (Pr)Detrol LA®

TORONTO, Jan. 6, 2016 /CNW/ - Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries Ltd., announced that Health Canada has approved its application for the generic versions of PrDetrol® ...


Nov 17, 2015, 10:38 ET Teva Canada Announces the Launch of (Pr)Teva-Pantoprazole Magnesium, a generic of (Pr)Tecta®

TORONTO, Nov. 17, 2015 /CNW/ - Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries Ltd., announced that Health Canada has approved its application for the generic version of PrTecta®. ...


Nov 10, 2015, 08:00 ET Teva Canada Announces the Launch of (Pr)Teva-Moxifloxacin Tablet, a generic of (Pr)Avelox®

TORONTO, Nov. 10, 2015 /CNW/ - Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries Ltd., announced that Health Canada has approved its application for a generic version of PrAvelox®...


Aug 27, 2015, 08:00 ET Teva Canada Announces the Launch of (Pr)Teva-Solifenacin, a generic of (Pr)Vesicare®

TORONTO, Aug. 27, 2015 /CNW/ - Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries Ltd., announced Health Canada's approval of its application for the generic version of PrVesicare®...


Mar 30, 2015, 14:04 ET Teva Canada Announces the Launch of (Pr)Bortezomib for Injection, a generic of (Pr)Velcade®

TORONTO, March 30, 2015 /CNW/ - Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries Ltd., announced that Health Canada has approved its application for the generic version of...


Dec 09, 2014, 09:00 ET Teva Canada Announces the Launch of (Pr)Teva-Erlotinib, a generic of (Pr)Tarceva®

TORONTO, Dec. 9, 2014 /CNW/ - Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries Ltd., announced today that Health Canada has approved its application for the generic version of...


Nov 18, 2014, 09:00 ET /R E P E A T -- Teva Canada Announces the Launch of (Pr)Teva-Celecoxib, a generic of (Pr)Celebrex®/

TORONTO, Nov. 17, 2014 /CNW/ - Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries Ltd., announced today that Health Canada has approved its application for the generic version of...


Nov 17, 2014, 17:16 ET Teva Canada Announces the Launch of (Pr)Teva-Celecoxib, a generic of (Pr)Celebrex®

TORONTO, Nov. 17, 2014 /CNW/ - Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries Ltd., announced today that Health Canada has approved its application for the generic version of...


Sep 15, 2014, 14:14 ET Teva Canada Announces the Launch of (Pr)Teva-Ezetimibe, a Generic of (Pr)Ezetrol®

TORONTO, Sept. 15, 2014 /CNW/ - Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries Ltd., announced today that Health Canada has approved its application for the generic version of...


Sep 10, 2014, 14:22 ET Teva Canada Announces the Launch of (Pr)Teva-Escitalopram, a Generic of (Pr)Cipralex®

TORONTO, Sept. 10, 2014 /CNW/ - Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries Ltd., announced today that Health Canada has approved its application for the generic version of...